Medtronic PLC (MDT) Shares Bought by Round Table Services LLC

Round Table Services LLC grew its stake in shares of Medtronic PLC (NYSE:MDT) by 27.8% during the 3rd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 6,623 shares of the medical technology company’s stock after purchasing an additional 1,440 shares during the period. Round Table Services LLC’s holdings in Medtronic were worth $515,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently modified their holdings of the business. BlackRock Inc. boosted its position in shares of Medtronic by 2,513.4% in the 1st quarter. BlackRock Inc. now owns 87,035,376 shares of the medical technology company’s stock worth $7,011,571,000 after buying an additional 83,705,052 shares in the last quarter. Lazard Asset Management LLC boosted its position in shares of Medtronic by 1,061.4% in the 1st quarter. Lazard Asset Management LLC now owns 13,678,772 shares of the medical technology company’s stock worth $1,101,960,000 after buying an additional 12,500,992 shares in the last quarter. Vanguard Group Inc. boosted its position in shares of Medtronic by 4.5% in the 1st quarter. Vanguard Group Inc. now owns 102,321,656 shares of the medical technology company’s stock worth $8,243,034,000 after buying an additional 4,412,536 shares in the last quarter. Alliancebernstein L.P. boosted its position in shares of Medtronic by 135.5% in the 2nd quarter. Alliancebernstein L.P. now owns 6,070,160 shares of the medical technology company’s stock worth $538,727,000 after buying an additional 3,493,058 shares in the last quarter. Finally, Sanders Capital LLC boosted its position in shares of Medtronic by 43.7% in the 2nd quarter. Sanders Capital LLC now owns 6,670,948 shares of the medical technology company’s stock worth $651,800,000 after buying an additional 2,027,147 shares in the last quarter. Institutional investors own 81.78% of the company’s stock.

In other news, EVP Bryan C. Hanson sold 16,000 shares of the company’s stock in a transaction dated Monday, October 16th. The shares were sold at an average price of $78.03, for a total transaction of $1,248,480.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Omar Ishrak sold 140,407 shares of the company’s stock in a transaction dated Friday, September 15th. The shares were sold at an average price of $81.63, for a total transaction of $11,461,423.41. Following the transaction, the chief executive officer now directly owns 668,503 shares of the company’s stock, valued at approximately $54,569,899.89. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 172,407 shares of company stock valued at $13,974,223. Corporate insiders own 0.31% of the company’s stock.

Medtronic PLC (NYSE:MDT) opened at $81.27 on Friday. Medtronic PLC has a 1-year low of $69.35 and a 1-year high of $89.72. The company has a quick ratio of 2.05, a current ratio of 2.40 and a debt-to-equity ratio of 0.50. The stock has a market cap of $110,006.42, a PE ratio of 17.52, a price-to-earnings-growth ratio of 2.24 and a beta of 1.00.

Medtronic (NYSE:MDT) last posted its quarterly earnings data on Tuesday, November 21st. The medical technology company reported $1.07 EPS for the quarter, beating the Zacks’ consensus estimate of $0.99 by $0.08. Medtronic had a net margin of 16.93% and a return on equity of 12.63%. The company had revenue of $7.05 billion during the quarter, compared to the consensus estimate of $7.05 billion. During the same quarter in the prior year, the company posted $1.12 EPS. The company’s quarterly revenue was down 4.0% compared to the same quarter last year. equities research analysts predict that Medtronic PLC will post 4.77 earnings per share for the current year.

Several equities research analysts recently commented on the stock. Jefferies Group reiterated a “buy” rating and issued a $99.00 price objective on shares of Medtronic in a research report on Thursday, November 23rd. Zacks Investment Research upgraded shares of Medtronic from a “sell” rating to a “hold” rating in a research report on Thursday, November 23rd. Northland Securities reiterated a “hold” rating and issued a $80.00 price objective on shares of Medtronic in a research report on Wednesday, November 22nd. Oppenheimer reiterated a “buy” rating and issued a $94.00 price objective on shares of Medtronic in a research report on Wednesday, November 22nd. Finally, Stifel Nicolaus boosted their price objective on shares of Medtronic from $83.00 to $85.00 and gave the stock a “hold” rating in a research report on Wednesday, November 22nd. Two research analysts have rated the stock with a sell rating, eleven have issued a hold rating and thirteen have issued a buy rating to the stock. The stock has an average rating of “Hold” and a consensus price target of $88.02.

COPYRIGHT VIOLATION WARNING: This news story was originally published by Community Financial News and is the sole property of of Community Financial News. If you are accessing this news story on another site, it was stolen and republished in violation of United States and international copyright law. The original version of this news story can be read at https://www.com-unik.info/2017/12/03/medtronic-plc-mdt-shares-bought-by-round-table-services-llc.html.

About Medtronic

Medtronic Public Limited Company (Medtronic) is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group.

Want to see what other hedge funds are holding MDT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medtronic PLC (NYSE:MDT).

Institutional Ownership by Quarter for Medtronic (NYSE:MDT)

What are top analysts saying about Medtronic PLC? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Medtronic PLC and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit